• 28 February 2019

    Study finds Guardant blood test as effective as tissue biopsy

    US-based precision oncology company Guardant Health has reported positive results from the NILE study of its blood test for identifying guideline-recommended biomarkers associated with first-line advanced non-small cell lung cancer.

Go Top